Bill Milgram, PhD.
President and CEO
Dr. Milgram is a co-founder of CanCog Technologies and the world's leading expert in the field of canine cognitive aging. He was instrumental in the successful development of Anipryl as an animal pharmaceutical licensed to Pfizer for treatment of Cognitive Dysfunction Syndrome in Dogs. More recently, Dr. Milgram has assisted in the development of the ProPlan Senior 7+ diet for dogs, Nutricks (cognitive dysfunction) and Sin Susto as an anxiolytic. Dr. Milgram's scientific qualification include over 150 refereed publications, over 100 abstracts, 2 edited books and 8 book chapters. He has also been a consultant to several animal health and pet food companies. Dr. Milgram has a PhD in behavioral Neuroscience from McGill University, is a professor emeritus at the University of Toronto and currently holds an appointment in the department of Pharmacology at the University of Toronto.
Gary Landsberg, D.V.M., DACVB, DECAWBM (behavior)
Vice President, Veterinary Affairs & Product Development
Dr. Landsberg is a board certified veterinary behaviorist, in both the American College of Veterinary Behaviorists and the European College of Veterinary Behavioural Medicine. When not at CanCog, he continues to see canine and feline behavior cases on a referral basis. He publishes, studies, researches and lectures extensively in field of veterinary behavior and has a special interest in canine and feline cognitive dysfunction. He is also the author of a clinical textbook in canine and feline behavior. As director of veterinary affairs, Dr. Landsberg aids in the development of new models for canine and feline behavior disorders and also serves as project coordinator for therapeutic trials.